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Abstract
Five aromatic nitrogen-containing heterocycles, pyridazine (pydz, 1), pyrimidine (pm, 2), 
pyrazine (pz, 3), quinoxaline (qx, 4) and phenazine (phz, 5) have been used for the 
synthesis of gold(III) and silver(I) complexes. In contrast to the mononuclear Au1-5 
complexes all having square-planar geometry, the corresponding Ag1-5 complexes have 
been found to be polynuclear and of different geometries. Complexes Au1-5 and Ag1-5, 
along with K[AuCl4], AgNO3 and N-heterocyclic ligands used for their synthesis, were 
evaluated by in vitro antimicrobial studies against a panel of microbial strains that lead to 
many skin and soft tissue, respiratory, wound and nosocomial infections. All tested 
complexes exhibited excellent to good antibacterial activity with minimal inhibitory (MIC) 
values in the range of 2.5 to 100 µg mL-1 against the investigated strains. The complexes 
were particularly efficient against pathogenic Pseudomonas aeruginosa (MIC = 2.5–30 µg 
mL-1) and had a marked ability to disrupt clinically relevant biofilms of strains with high 
inherent resistance to antibiotics. Moreover, the Au1-4 and Ag1-5 complexes exhibited 
pronounced ability to competitively intercalate double stranded bacterial genomic DNA of 
P. aeruginosa, which was demonstrated by gel electrophoresis techniques and supported 
by molecular docking into the DNA major groove. Antiproliferative effect on the normal 
human lung fibroblast cell line MRC5 has also been evaluated in order to determine 
therapeutic potential of Au1-5 and Ag1-5 complexes. Since the investigated gold(III) 
complexes showed much lower negative effects on the viability of the MRC5 cell line than 
their silver(I) analogues and slightly lower antimicrobial activity against the investigated 
strains, the combination approach to improve their pharamacological profiles was applied. 
Synergistic antimicrobial effect and the selectivity index of 10 were achieved for the 
selected gold(III)/silver(I) complexes mixtures, as well as higher P. aeruginosa PAO1 
biofilm disruption activity, and improved toxicity profile towards zebrafish embryos, in 
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comparison to the single complexes. To the best of our knowledge, this is the first report on 
synergistic activity of gold(III)/silver(I) complexes mixtures and it could have an impact on 
development of new combination therapy  methods for the treatment of multi-resistant 
bacterial infections.
Keywords: Silver(I) complexes; Gold(III) complexes; Antibacterial activity; Cytotoxicity; 
Danio rerio; Synergism
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Fig. S1 Air/light stability of Au1-5 and Ag1-5 complexes. Sterile cellulose discs were impregnated with these complexes and exposed to air and 
light within 96 h.
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Fig. S2 Computational docking model illustrating interactions between DNA and all 
studied Au(III) complexes.
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Fig. S3 Computational docking model illustrating interactions between DNA and all 
studied Ag(I) complexes.
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Fig. S4 Representative fluorescent microscopy image of a P. aeruginosa PAO1 mature 
biofilm, treated with mixture of Au1/Ag1 (8:1) and Au3/Ag1 (6.4:1). Bar represents 10 
μm.
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Table S1 Comparison of MIC values (µg mL-1) of the investigated gold(III) and silver(I) 
compounds in different incubation media 
Pseudomonas aeruginosa PAO1
Complex LB No serum Serum
Au1 10 ± 1 10 ± 0.3 20 ± 0.8
Ag1 2.5 ± 0.1 5 ± 0.1 5 ± 0.1
Au2 15 ± 1 15.6 ± 1 31.2 ± 1
Ag2 2.5 ± 0.1 5 ± 0.1 10 ± 0.1
Au3 8 ± 0.5 15.6 ± 0.5 15.6 ± 1
Ag3 7.8 ± 0.5 10 ± 0.4 10 ± 0.6
Au4 12.5 ± 0.5 15.6 ± 0.5 31.2 ± 0.8
Ag4 15.6 ± 0.5 15.6 ± 0.5 15.6 ± 0.5
Au5 30 ± 4 62.5 ± 6 62.5 ± 6
Ag5 7.8 ± 4 15.6 ± 4 15.6 ± 4
K[AuCl4] 8 ± 0.5 15.6 ± 0.5 31.2 ± 1
AgNO3 3.1 ± 0.1 5 ± 0.1 5 ± 0.1
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Table S2 Effect percentages for abnormal morphological characteristics evaluated in the zebrafish teratogenicty assay at 114 hpf
Compound 
concentration
Dead  
embryosa
Teratogenic 
embryosa
Normal 
embryosa
Growth 
retardationb
Notochordb  Eyesb Otolithsb Pericardial 
edemab
Yolk   
edemab
Heart           
beatb
Blood 
circulationb
Unhatchedb Head 
malformationc
Skeletal 
deformitiesc
Ag1
50 µg/mL 100.00 0.00 0.00  -  - - - - - - - - - - 
25 µg/mL 100.00 0.00 0.00  -  - - - - - - - - - - 
10 µg/mL 95.83 4.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00 100.00
5 µg/mL 25.00 75.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00 100.00
Au1
50 µg/mL 100.00 0.00 0.00  -  - - - - - - - - - - 
25 µg/mL 58.33 41.67 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00 0.00 0.00 0.00 0.00
10 µg/mL 0.00 100.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00 0.00 0.00 0.00 0.00
5 µg/mL 0.00 8.33 91.67 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Au3
50 µg/mL 100.00 0.00 0.00  - - - - - - - - - -  
25 µg/mL 95.83 4.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00  n.d.  n.d.
10 µg/mL 62.50 37.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100.00  n.d.  n.d.
5 µg/mL 8.33 12.50 79.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.64
Au1/Ag1 8:1
50 µg/mL 100.00 0.00 0.00  -  - - - - - - - - - - 
25 µg/mL 62.50 0.00 37.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
10 µg/mL 0.00 0.00 100.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5 µg/mL 0.00 0.00 100.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Au3/Ag1 6.4:1
50 µg/mL 100.00 0.00 0.00  -  - - - - - - - - - - 
25 µg/mL 62.50 0.00 37.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
10 µg/mL 0.00 0.00 100.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5 µg/mL 0.00 0.00 100.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Abbreviation used: (hpf) hours post fertilization; (-) data not available due to 100% mortality; (n.d.) not detected.
a Percentage of mortality based on all eggs.
b Percentage of teratogenic effect based on all alive embryos at the time of assessment.
c Percentage of teratogenic effect based on all alive hatched embryos at the time of assessment.
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Table S3 Lethal and teratogenic effects observed in zebrafish (Danio rerio) embryos at 
different hours post fertilization (hpf)
Category Developmental endpoints Exposure time (hpf)
24 48 72 96 /114
Lethal effect Egg coagulationa ● ● ● ●
No somite formation ● ● ● ●
Tail not detached ● ● ● ●
No heartbeat ● ● ●
Teratogenic effect Malformation of head ● ● ● ●
Malformation of eyesb ● ● ● ●
Malformation of sacculi/otolithsc ● ● ● ●
Malformation of chorda ● ● ● ●
Malformation of taild ● ● ● ●
Scoliosis ● ● ● ●
Heart beat frequency ● ● ●
Blood circulation ● ● ●
Pericardial edema ● ● ● ●
Yolk edema ● ● ● ●
Yolk deformation ● ● ● ●
Growth retardatione ● ● ● ●
a No clear organs structure is recognized.
b Malformation of eyes was recorded for the retardation in eye development and abnormality in  shape and size.
c Presence of no, one or more than two otoliths per sacculus, as well as reduction and enlargement of otoliths and/or 
sacculi (otic vesicles).
d Tail malformation was recorded when the tail was bent, twisted or shorter than to control embryos as assessed by 
optical comparation.
e Growth retardation was recorded by comparing with the control embryos in development or size (before hatching, at 24 
hpf and 48 hpf) or in a body length (after hatching, at and onwards 72 hpf) using by optical comparation using a inverted 
microscope (CKX41; Olympus, Tokyo, Japan).
